SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-499535
Filing Date
2012-12-12
Accepted
2012-12-12 10:28:21
Documents
11
Period of Report
2013-01-23
Effectiveness Date
2012-12-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A d434025ddef14a.htm DEF 14A 635032
2 GRAPHIC g434025g05d10.jpg GRAPHIC 32355
3 GRAPHIC g434025g20j99.jpg GRAPHIC 16041
4 GRAPHIC g434025g23w50.jpg GRAPHIC 13600
5 GRAPHIC g434025g35m57.jpg GRAPHIC 13654
6 GRAPHIC g434025g44w66.jpg GRAPHIC 13634
7 GRAPHIC g434025g51t91.jpg GRAPHIC 16011
8 GRAPHIC g434025g54u87.jpg GRAPHIC 32327
9 GRAPHIC g434025g73x56.jpg GRAPHIC 13542
10 GRAPHIC g434025g81u94.jpg GRAPHIC 13561
11 GRAPHIC g434025g96j26.jpg GRAPHIC 13643
  Complete submission text file 0001193125-12-499535.txt   883405
Mailing Address 3471 RIVER HILLS DRIVE CINCINNATI OH 45244
Business Address 3471 RIVER HILLS DR CINCINNATI OH 45244 5132713700
MERIDIAN BIOSCIENCE INC (Filer) CIK: 0000794172 (see all company filings)

IRS No.: 310888197 | State of Incorp.: OH | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 000-14902 | Film No.: 121258019
SIC: 2835 In Vitro & In Vivo Diagnostic Substances